跳至主要内容
临床试验/NCT05578456
NCT05578456尚未招募4 期

Effect of Prednisone and Aspirin on Pregnancy Outcomes After Embryo Transfer Among Patients With Thyroid Autoimmunity: a Randomized Clinical Trial

Second Affiliated Hospital, School of Medicine, Zhejiang University0 个研究点目标入组 540 人开始时间: 2022年11月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
540
主要终点
clinical pregnancy rate

研究概览

简要总结

This trial was a 1:1 (active:placebo) randomized, double-blind, placebo-controlled trial to evaluate the safety and efficacy of prednisone and aspirin for the in vitro fertilization and embryo transfer outcome among patients with thyroid autoimmunity.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 38 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • TPOAb>34IU/ml and/or TgAb>115IU/ml
  • ≥5 follicles with average diameter lager than 14 mm at trigger day
  • ≥5 oocytes retrieved
  • for frozen embryo transfer, at least 2 cleavage stage embryos, among which at least one morphologically good quality embryo, or at least 1 morphologically good quality embryo in blastocyst stage
  • age: 20-38 years old
  • Patients whose written ICF approved by the EC has been obtained, after having been duly informed of the nature of the study and voluntarily accepted to participate after being fully aware of the potential risks, benefits and any discomfort involved.
  • meet item 1, 5, 6, and one of item 2, 3, 4.

排除标准

  • hyperthyroidism
  • intrauterine adhesion
  • with endometrium thickness less than 6mm
  • uterine malformation
  • with other autoimmune diseases need glucocorticoid or aspirin treatment
  • gastric ulcer

研究组 & 干预措施

prednisone and aspirin

Experimental

干预措施: Prednisone and Aspirin (Drug)

placebo

Placebo Comparator

干预措施: Placebo (Drug)

结局指标

主要结局

clinical pregnancy rate

时间窗: 3-5 weeks after embryo transfer

ultrasound visualization of the gestational sac

次要结局

未报告次要终点

研究者

发起方
Second Affiliated Hospital, School of Medicine, Zhejiang University
申办方类型
Other
责任方
Sponsor

相似试验